metformin has been researched along with Cirrhoses, Experimental Liver in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin sensitivity was determined by euglycemic hyperinsulinemic clamp." | 1.48 | Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats. ( Liu, CH; Tang, LR; Tao, YY; Wang, HN, 2018) |
| "Metformin treatment remarkably improved liver function, alleviated lipid peroxidation and histological damages of the liver, and ameliorated glucose intolerance and insulin resistance." | 1.43 | Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. ( Chen, F; Liu, Y; Ping, J; Ruo, R; Shou, Q; Xu, H; Zhou, Y, 2016) |
| "The animal model of type 2 diabetes with hepatic fibrosis was successfully made." | 1.36 | [Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats]. ( Chen, BN; Du, GH; Qiang, GF; Shi, LL; Xuan, Q; Yang, XY; Zhang, HA; Zhang, L, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moheimani, HR | 1 |
| Amiriani, T | 1 |
| Alizadeh, AM | 1 |
| Jand, Y | 1 |
| Shakiba, D | 1 |
| Ensan, PS | 1 |
| Jafarzadeh, F | 1 |
| Rajaei, M | 1 |
| Enayati, A | 1 |
| Pourabouk, M | 1 |
| Aliazadeh, S | 1 |
| Pourkhani, AH | 1 |
| Mazaheri, Z | 1 |
| Zeyghami, MA | 1 |
| Dehpour, A | 1 |
| Khori, V | 1 |
| Sato, Y | 2 |
| Qiu, J | 1 |
| Hirose, T | 1 |
| Miura, T | 1 |
| Kohzuki, M | 1 |
| Ito, O | 1 |
| Tang, LR | 1 |
| Tao, YY | 1 |
| Liu, CH | 1 |
| Wang, HN | 1 |
| Xu, H | 1 |
| Zhou, Y | 1 |
| Liu, Y | 1 |
| Ping, J | 1 |
| Shou, Q | 1 |
| Chen, F | 1 |
| Ruo, R | 1 |
| Qiang, GF | 1 |
| Zhang, L | 1 |
| Xuan, Q | 1 |
| Yang, XY | 1 |
| Shi, LL | 1 |
| Zhang, HA | 1 |
| Chen, BN | 1 |
| Du, GH | 1 |
5 other studies available for metformin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Preconditioning and anti-apoptotic effects of Metformin and Cyclosporine-A in an isolated bile duct-ligated rat heart.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Bile Ducts; Cardio | 2021 |
Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.
Topics: AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cysts; Disease Progression; Enzyme Activ | 2021 |
Salvianolate Reduces Glucose Metabolism Disorders in Dimethylnitrosamine-Induced Cirrhotic Rats.
Topics: Animals; Dimethylnitrosamine; Glucose; Glucose Tolerance Test; Insulin Resistance; Liver; Liver Cirr | 2018 |
Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis.
Topics: Animals; Glucose Intolerance; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resi | 2016 |
[Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats].
Topics: Actins; Animals; Apoptosis; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Me | 2010 |